|
Variables
| |
CS (n = 560)
|
TPS (n = 89)
|
P values*
|
|---|
|
Mean age
|
Years (range)
|
73.1 (31–100)
|
73.5 (26–93)
|
0.39
|
|
Sex
|
|
Male
|
No. (%)
|
487 (87.0)
|
77 (86.5)
|
0.91
|
|
Female
|
No. (%)
|
73 (13.0)
|
12 (13.5)
|
|
Prior recurrence status
|
|
Primary
|
No. (%)
|
339 (60.5)
|
68 (76.4)
|
< 0.01
|
|
Recurrent
|
No. (%)
|
221 (39.5)
|
21 (23.6)
|
|
Prior TUR within 90 days
|
|
Yes
|
No. (%)
|
82 (14.6)
|
27 (30.3)
|
< 0.01
|
|
No
|
No. (%)
|
478 (85.4)
|
62 (69.7)
|
|
Tumor appearance
|
|
Papillary
|
No. (%)
|
478 (85.4)
|
78 (87.6)
|
0.57
|
|
Solid
|
No. (%)
|
82 (14.6)
|
11 (12.4)
|
|
Tumor number
|
|
Solitary
|
No. (%)
|
389 (69.5)
|
58 (65.1)
|
0.42
|
|
Multiple
|
No. (%)
|
171 (30.5)
|
31 (34.9)
|
|
Largest tumor diameter
|
|
< 3 cm
|
No. (%)
|
532 (95.0)
|
80 (89.9)
|
0.05
|
|
≥ 3 cm
|
No. (%)
|
28 (5.0)
|
9 (10.1)
|
|
High-grade tumor
|
|
Yes
|
No. (%)
|
313 (55.9)
|
42 (47.2)
|
0.13
|
|
No
|
No. (%)
|
247 (44.1)
|
47 (52.8)
|
|
Pathological tumor stage (Benign vs pT+)
|
|
Benign
|
No. (%)
|
108 (19.2)
|
25 (28.1)
|
0.06
|
|
pTis
|
No. (%)
|
49 (8.8)
|
8 (9.0)
|
|
pTa
|
No. (%)
|
243 (43.4)
|
31 (34.8)
|
|
pT1
|
No. (%)
|
117 (20.9)
|
16 (18.0)
|
|
≥ pT2
|
No. (%)
|
43 (7.7)
|
9 (10.1)
|
|
Concomitant CIS
|
|
Yes
|
No. (%)
|
120 (21.4)
|
18 (20.2)
|
0.79
|
|
No
|
No. (%)
|
440 (78.6)
|
71 (79.8)
|
- CS conventional systems, TPS The Paris System, TUR transurethral resection, CIS carcinoma in situ
- *P values were estimated using using the Mann–Whitney U test or the Fisher’s exact test
